- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Report
- June 2023
- 159 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- January 2024
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- November 2023
- 185 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 180 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 170 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Report
- June 2023
- 157 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- September 2023
- 274 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- December 2023
- 223 Pages
Global
€4851EUR$4,995USD£4,185GBP
- Report
- October 2023
- 82 Pages
United States
From €3399EUR$3,500USD£2,933GBP
- Report
- September 2023
- 132 Pages
Middle East, Africa
From €1457EUR$1,500USD£1,257GBP
Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more